Sonnet Biotherapeutics, Inc. — Form D
Sonnet Biotherapeutics, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-14. The offering totals $750K, of which $750K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-05-14
- Form: D
- Accession: 0001776263-19-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $750K
- Amount sold: $750K
- Investors: 7
- Date of first sale: 2019-04-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-339578
Issuer
- Name: Sonnet Biotherapeutics, Inc.
- CIK: 0001776628
- Entity type: Corporation
- Jurisdiction: NEW JERSEY
- Incorporated: 2015
- Address: 100 OVERLOOK CENTER, PRINCETON, NJ, 08540
- Phone: 609-375-2227
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Pankaj Mohan | Director | Princeton, NJ |
| John Cini | Executive Officer | Princeton, NJ |
| Susan Dexter | Executive Officer | Ottawa, A6 |
| Donald Griffith | Executive Officer | Princeton, NJ |
| Pankaj Mohan | Executive Officer | Princeton, NJ |
| Terence Rugg | Executive Officer | Princeton, NJ |
More